Skip to main content
. 2021 Mar 7;22(5):2690. doi: 10.3390/ijms22052690

Figure 4.

Figure 4

Overall survival of patients with colorectal cancer classified according to CD47, SIRPA, CD68, and CD163 expression. Kaplan–Meier curves for patients classified by CD47 (a), SIRPA (b), CD68 (c), and CD163 (d) expression. (a) Patients with CD47-positive CRC had significantly worse overall survival (p = 0.0268). (bd) Overall survival was not correlated with the presence of SIRPA- (b), CD68- (c), or CD163-positive TAIs.